Method for determining the nature of an infection
View Patent ↗The present invention relates to differential diagnostics, and provides a method for determining if an infection detected in a patient is of bacterial or of viral origin. In the method chemiluminescence of phagocytic cells induced by non-opsonized zymosan in a blood sample is measured and the expression of Complement Receptor 1 (cr1) is determined. The value when multiplying chemiluminescence with the CR1 expression is compared with method-specific average values for bacterial and viral infections. The invention also provides test kits for accomplishing the method of the invention.
1. A method for distinguishing a bacterial infection from a viral infection in a patient, comprising the steps of
(a) measuring in a whole blood sample taken from said patient chemiluminescence of phagocytic cells in said whole blood sample induced by non-opsonized zymosan (NWBCL), expressed per blood volume,
(b) separating in the blood sample erythrocytes from leukocytes by lysis,
(c) determining in the leukocytes the expression of Complement Receptor 1 (CR1),
(d) multiplying the value obtained at step (a) by the value obtained at step (c) using the equation CR1×NWBCL/μl whole blood,
(e) comparing the value obtained from step (d) to the mean+/−the standard deviation (SD) of the average values obtained from samples having a confirmed viral or a confirmed bacterial infection wherein when:
(i) the value from the patient is numerically higher than the mean+/−the SD value obtained from the samples having the confirmed viral infection, the patient is determined to have a bacterial infection,
(ii) the value from the patient is numerically equal to the mean+/−the SD value obtained from the samples having a confirmed viral infection, the patient is determined to have a viral infection,
(iii) the value from the patient is numerically lower than the mean+/−the SD value obtained from the samples having the confirmed bacterial infection, the patient is determined to have a viral infection, and
(iv) the value from the patient is numerically equal to the mean+/−the SD value obtained from a sample having the confirmed bacterial infection, the patient is determined to have a bacterial infection.
2. The method according to claim 1 , wherein the blood sample comprises heparin as an anticoagulant.
3. The method according to claim 1 , wherein the zymosan used is sonicated zymosan.
4. The method according to claim 1 , wherein the determinations from the blood samples are carried out within two hours, preferably within one hour from collecting the blood sample.
5. The method according to claim 1 , comprising a further step of detecting the Erythrocyte Sedimentation Rate (ESR) value in a blood sample from the patient, and multiplying the value obtained at step (d) with said ESR value.
6. The method according to claim 5 , wherein CR1×NWBCL/μl whole blood×ESR is used, wherein CR1 is the expression of Complement Receptor 1.
7. The method according to claim 1 , wherein the CR1 expression is determined flow cytometrically.
8. The method according to claim 1 , wherein the CR1 expression is determined luminometrically.